English 
Chinese 
Russian 
French Paying for Stem Cell Therapy Abroad: Costs & Coverage
What insurance actually covers (rarely anything), the financing options patients genuinely use, and the two arrangements we tell everyone to avoid.
13Nov
12Nov
After a Stem Cell Injection: Painkillers, Exercise, Swelling
What you can actually do in the days after a stem cell injection: which painkillers are safe, what swelling means, how fast to move, and when to call.
11Nov
Stem Cell Therapy: Thailand vs USA and Europe in 2026
Cost gaps, regulatory trade-offs, and wait times compared honestly — including the three areas where the USA and Europe are genuinely the better choice.
10Nov
Stem Cell Therapy for Diabetic Peripheral Neuropathy: Pilot Data, Schwann Cell Mechanisms, and the Exosome Shift
Two 2026 systematic reviews, a Schwann cell mechanism study, and the first powered RCT in diabetic peripheral neuropathy — what clinicians need to know about MSC and exosome therapy for DPN.
09Nov
MSC Therapy for Multiple Sclerosis: 2026 RCT Data & Meta-Analysis
Reviewing the latest RCTs (SMART-MS) and meta-analyses on MSC therapy for progressive multiple sclerosis, including efficacy and safety data.
09Nov
Mesenchymal Stem Cell Therapy in Cervical Cancer: What the 2026 Evidence Shows
A 2026 systematic review found 14 studies of mesenchymal stem cells in cervical cancer, with contradictory results and no study controlling for HPV genotype. Here is what the evidence actually shows.
02Nov
Glycocalyx-Edited MSC Therapy for Advanced Osteoporosis: First-in-Human Trial Results Published in Cell
The first-in-human trial of glycocalyx-edited autologous MSCs shows that engineering bone homing via sLeX expression reduces fragility fractures and increases bone density in advanced osteoporosis patients, with five-plus years of safety data and no serious adverse events.
28Oct
MSC Therapy for Traumatic Brain Injury: Phase 1/2a Results Show Reduced Brain Inflammation and Clinical Improvement
The Cox et al. Phase 1/2a trial in Brain (2026) demonstrates that autologous adipose-derived MSCs reduce brain immune cell density and improve depression, fatigue, and pain in chronic TBI patients.
24Oct
Stem Cell Therapy for Hair Loss in 2026: What the Science Actually Shows
From MSC secretome to exosome injections and next-gen PRP alternatives, here is what 2026 research says about regenerative hair loss treatments — and who they work best for.
22Oct
MSC Therapy for Alzheimer’s Disease: Clinical Trial Data on Laromestrocel and Biomarker Outcomes
Recent Phase 2a clinical trials demonstrate that mesenchymal stem cell therapy can slow brain atrophy by up to 62% and reduce neuroinflammation in mild Alzheimer's patients. Review of laromestrocel trial data, biomarker outcomes, and emerging treatment options.